262 related articles for article (PubMed ID: 21085091)
1. Syringe exchange programs --- United States, 2008.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2010 Nov; 59(45):1488-91. PubMed ID: 21085091
[TBL] [Abstract][Full Text] [Related]
2. Syringe exchange programs--United States, 2005.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2007 Nov; 56(44):1164-7. PubMed ID: 17989646
[TBL] [Abstract][Full Text] [Related]
3. Doing harm reduction better: syringe exchange in the United States.
Des Jarlais DC; McKnight C; Goldblatt C; Purchase D
Addiction; 2009 Sep; 104(9):1441-6. PubMed ID: 19215605
[TBL] [Abstract][Full Text] [Related]
4. Update: syringe exchange programs--United States, 2002.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2005 Jul; 54(27):673-6. PubMed ID: 16015218
[TBL] [Abstract][Full Text] [Related]
5. Integrating multiple programme and policy approaches to hepatitis C prevention and care for injection drug users: a comprehensive approach.
Birkhead GS; Klein SJ; Candelas AR; O'Connell DA; Rothman JR; Feldman IS; Tsui DS; Cotroneo RA; Flanigan CA
Int J Drug Policy; 2007 Oct; 18(5):417-25. PubMed ID: 17854731
[TBL] [Abstract][Full Text] [Related]
6. Update: syringe exchange programs--United States, 1998.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2001 May; 50(19):384-7. PubMed ID: 11465907
[TBL] [Abstract][Full Text] [Related]
7. Update: syringe-exchange programs--United States, 1996.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 1997 Jun; 46(24):565-8. PubMed ID: 9221326
[TBL] [Abstract][Full Text] [Related]
8. The role of needle exchange programs in HIV prevention.
Vlahov D; Junge B
Public Health Rep; 1998 Jun; 113 Suppl 1(Suppl 1):75-80. PubMed ID: 9722812
[TBL] [Abstract][Full Text] [Related]
9. Update: syringe exchange programs--United States, 1997.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 1998 Aug; 47(31):652-5. PubMed ID: 9716397
[TBL] [Abstract][Full Text] [Related]
10. Unmet need for recommended preventive health services among clients of California syringe exchange programs: implications for quality improvement.
Heinzerling KG; Kral AH; Flynn NM; Anderson RL; Scott A; Gilbert ML; Asch SM; Bluthenthal RN
Drug Alcohol Depend; 2006 Feb; 81(2):167-78. PubMed ID: 16043308
[TBL] [Abstract][Full Text] [Related]
11. Strategies to improve access to sterile syringes for injection drug users.
Rich JD; Wolf FA; Macalino G
AIDS Read; 2002 Dec; 12(12):527-35. PubMed ID: 12518719
[TBL] [Abstract][Full Text] [Related]
12. Syringe exchange programs: lowering the transmission of syringe-borne diseases and beyond.
Heimer R
Public Health Rep; 1998 Jun; 113 Suppl 1(Suppl 1):67-74. PubMed ID: 9722811
[TBL] [Abstract][Full Text] [Related]
13. Public funding of US syringe exchange programs.
Des Jarlais DC; McKnight C; Milliken J
J Urban Health; 2004 Mar; 81(1):118-21. PubMed ID: 15047790
[TBL] [Abstract][Full Text] [Related]
14. Human immunodeficiency virus and hepatitis C virus testing services at syringe exchange programs: availability and outcomes.
Heinzerling KG; Kral AH; Flynn NM; Anderson RL; Scott A; Gilbert ML; Asch SM; Bluthenthal RN
J Subst Abuse Treat; 2007 Jun; 32(4):423-9. PubMed ID: 17481466
[TBL] [Abstract][Full Text] [Related]
15. Sterile syringe access conditions and variations in HIV risk among drug injectors in three cities.
Bluthenthal RN; Malik MR; Grau LE; Singer M; Marshall P; Heimer R;
Addiction; 2004 Sep; 99(9):1136-46. PubMed ID: 15317634
[TBL] [Abstract][Full Text] [Related]
16. Minimal uptake of sterile drug preparation equipment in a predominantly cocaine injecting population: implications for HIV and hepatitis C prevention.
Morissette C; Cox J; De P; Tremblay C; Roy E; Allard R; Stephenson R; Graves L
Int J Drug Policy; 2007 May; 18(3):204-12. PubMed ID: 17689367
[TBL] [Abstract][Full Text] [Related]
17. Unsafe injections in the developing world and transmission of bloodborne pathogens: a review.
Simonsen L; Kane A; Lloyd J; Zaffran M; Kane M
Bull World Health Organ; 1999; 77(10):789-800. PubMed ID: 10593026
[TBL] [Abstract][Full Text] [Related]
18. Evidence for the effectiveness of sterile injecting equipment provision in preventing hepatitis C and human immunodeficiency virus transmission among injecting drug users: a review of reviews.
Palmateer N; Kimber J; Hickman M; Hutchinson S; Rhodes T; Goldberg D
Addiction; 2010 May; 105(5):844-59. PubMed ID: 20219055
[TBL] [Abstract][Full Text] [Related]
19. Correlates of syringe coverage for heroin injection in 35 large metropolitan areas in the US in which heroin is the dominant injected drug.
Tempalski B; Cooper HL; Friedman SR; Des Jarlais DC; Brady J; Gostnell K
Int J Drug Policy; 2008 Apr; 19 Suppl 1(Suppl 1):S47-58. PubMed ID: 18295468
[TBL] [Abstract][Full Text] [Related]
20. Integrating hepatitis, STD, and HIV services into a drug rehabilitation program.
Gunn RA; Lee MA; Callahan DB; Gonzales P; Murray PJ; Margolis HS
Am J Prev Med; 2005 Jul; 29(1):27-33. PubMed ID: 15958248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
